Cargando…
A Comprehensive Commentary on the Multilocular Cystic Renal Neoplasm of Low Malignant Potential: A Urologist’s Perspective
SIMPLE SUMMARY: Multilocular cystic renal neoplasm of low malignant potential (MCRNLMP) is a cystic renal neoplasm with an excellent prognosis. This neoplasm was previously named as “multilocular cystic renal cell carcinoma”, which is now considered obsolete. In 2016, the WHO distinguished this neop...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834316/ https://www.ncbi.nlm.nih.gov/pubmed/35159098 http://dx.doi.org/10.3390/cancers14030831 |
_version_ | 1784649156873158656 |
---|---|
author | Pitra, Tomas Pivovarcikova, Kristyna Alaghehbandan, Reza Bartos Vesela, Adriena Tupy, Radek Hora, Milan Hes, Ondrej |
author_facet | Pitra, Tomas Pivovarcikova, Kristyna Alaghehbandan, Reza Bartos Vesela, Adriena Tupy, Radek Hora, Milan Hes, Ondrej |
author_sort | Pitra, Tomas |
collection | PubMed |
description | SIMPLE SUMMARY: Multilocular cystic renal neoplasm of low malignant potential (MCRNLMP) is a cystic renal neoplasm with an excellent prognosis. This neoplasm was previously named as “multilocular cystic renal cell carcinoma”, which is now considered obsolete. In 2016, the WHO distinguished this neoplasm of low malignant potential from cystic renal cell carcinomas, which have some overlapping morphologic features. ABSTRACT: Multilocular cystic renal neoplasm of low malignant potential (MCRNLMP) is a cystic renal tumor with indolent clinical behavior. In most of cases, it is an incidental finding during the examination of other health issues. The true incidence rate is estimated to be between 1.5% and 4% of all RCCs. These lesions are classified according to the Bosniak classification as Bosniak category III. There is a wide spectrum of diagnostic tools that can be utilized in the identification of this tumor, such as computed tomography (CT), magnetic resonance (MRI) or contrast-enhanced ultrasonography (CEUS). Management choices of these lesions range from conservative approaches, such as clinical follow-up, to surgery. Minimally invasive techniques (i.e., robotic surgery and laparoscopy) are preferred, with an emphasis on nephron sparing surgery, if clinically feasible. |
format | Online Article Text |
id | pubmed-8834316 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88343162022-02-12 A Comprehensive Commentary on the Multilocular Cystic Renal Neoplasm of Low Malignant Potential: A Urologist’s Perspective Pitra, Tomas Pivovarcikova, Kristyna Alaghehbandan, Reza Bartos Vesela, Adriena Tupy, Radek Hora, Milan Hes, Ondrej Cancers (Basel) Commentary SIMPLE SUMMARY: Multilocular cystic renal neoplasm of low malignant potential (MCRNLMP) is a cystic renal neoplasm with an excellent prognosis. This neoplasm was previously named as “multilocular cystic renal cell carcinoma”, which is now considered obsolete. In 2016, the WHO distinguished this neoplasm of low malignant potential from cystic renal cell carcinomas, which have some overlapping morphologic features. ABSTRACT: Multilocular cystic renal neoplasm of low malignant potential (MCRNLMP) is a cystic renal tumor with indolent clinical behavior. In most of cases, it is an incidental finding during the examination of other health issues. The true incidence rate is estimated to be between 1.5% and 4% of all RCCs. These lesions are classified according to the Bosniak classification as Bosniak category III. There is a wide spectrum of diagnostic tools that can be utilized in the identification of this tumor, such as computed tomography (CT), magnetic resonance (MRI) or contrast-enhanced ultrasonography (CEUS). Management choices of these lesions range from conservative approaches, such as clinical follow-up, to surgery. Minimally invasive techniques (i.e., robotic surgery and laparoscopy) are preferred, with an emphasis on nephron sparing surgery, if clinically feasible. MDPI 2022-02-06 /pmc/articles/PMC8834316/ /pubmed/35159098 http://dx.doi.org/10.3390/cancers14030831 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Commentary Pitra, Tomas Pivovarcikova, Kristyna Alaghehbandan, Reza Bartos Vesela, Adriena Tupy, Radek Hora, Milan Hes, Ondrej A Comprehensive Commentary on the Multilocular Cystic Renal Neoplasm of Low Malignant Potential: A Urologist’s Perspective |
title | A Comprehensive Commentary on the Multilocular Cystic Renal Neoplasm of Low Malignant Potential: A Urologist’s Perspective |
title_full | A Comprehensive Commentary on the Multilocular Cystic Renal Neoplasm of Low Malignant Potential: A Urologist’s Perspective |
title_fullStr | A Comprehensive Commentary on the Multilocular Cystic Renal Neoplasm of Low Malignant Potential: A Urologist’s Perspective |
title_full_unstemmed | A Comprehensive Commentary on the Multilocular Cystic Renal Neoplasm of Low Malignant Potential: A Urologist’s Perspective |
title_short | A Comprehensive Commentary on the Multilocular Cystic Renal Neoplasm of Low Malignant Potential: A Urologist’s Perspective |
title_sort | comprehensive commentary on the multilocular cystic renal neoplasm of low malignant potential: a urologist’s perspective |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834316/ https://www.ncbi.nlm.nih.gov/pubmed/35159098 http://dx.doi.org/10.3390/cancers14030831 |
work_keys_str_mv | AT pitratomas acomprehensivecommentaryonthemultilocularcysticrenalneoplasmoflowmalignantpotentialaurologistsperspective AT pivovarcikovakristyna acomprehensivecommentaryonthemultilocularcysticrenalneoplasmoflowmalignantpotentialaurologistsperspective AT alaghehbandanreza acomprehensivecommentaryonthemultilocularcysticrenalneoplasmoflowmalignantpotentialaurologistsperspective AT bartosveselaadriena acomprehensivecommentaryonthemultilocularcysticrenalneoplasmoflowmalignantpotentialaurologistsperspective AT tupyradek acomprehensivecommentaryonthemultilocularcysticrenalneoplasmoflowmalignantpotentialaurologistsperspective AT horamilan acomprehensivecommentaryonthemultilocularcysticrenalneoplasmoflowmalignantpotentialaurologistsperspective AT hesondrej acomprehensivecommentaryonthemultilocularcysticrenalneoplasmoflowmalignantpotentialaurologistsperspective AT pitratomas comprehensivecommentaryonthemultilocularcysticrenalneoplasmoflowmalignantpotentialaurologistsperspective AT pivovarcikovakristyna comprehensivecommentaryonthemultilocularcysticrenalneoplasmoflowmalignantpotentialaurologistsperspective AT alaghehbandanreza comprehensivecommentaryonthemultilocularcysticrenalneoplasmoflowmalignantpotentialaurologistsperspective AT bartosveselaadriena comprehensivecommentaryonthemultilocularcysticrenalneoplasmoflowmalignantpotentialaurologistsperspective AT tupyradek comprehensivecommentaryonthemultilocularcysticrenalneoplasmoflowmalignantpotentialaurologistsperspective AT horamilan comprehensivecommentaryonthemultilocularcysticrenalneoplasmoflowmalignantpotentialaurologistsperspective AT hesondrej comprehensivecommentaryonthemultilocularcysticrenalneoplasmoflowmalignantpotentialaurologistsperspective |